Table 2 Pre-treatment and post-treatment clinical characteristics of the patients
From: Factors affectıng recurrence after trımodal treatment ın ınvasıve bladder cancer
Recurrence ( +) patients (n = 52) | Recurrence (−) patients (n = 60) | P | |
|---|---|---|---|
Duration of follow-up (months) | 53 ± 22,4 | 51,07 ± 14,80 | 0.104 |
Number of tumor foci (n) | 0.008 | ||
Single focus | 22 (42.3%) | 48 (80%) | |
Two foci | 4 (7.7%) | 4(6.6%) | |
3 or more | 26 (50%) | 8 (13.3%) | |
Tumor diameter (cm) | 5.69 ± 2.55 | 4.20 ± 1.44 | 0.08 |
Tumor location (n) | 0.003 | ||
Right lateral wall | 10 (19.2%) | 28 (46.6%) | |
Left lateral wall | 10 (19.2%) | 14 (23.3%) | |
Posterior wall | 2 (3.8%) | 8 (13.3%) | |
Trigone | 2 (3.8%) | 4 (6.6%) | |
Multiple foci | 26 (50%) | 6 (10%) | |
Dome | 2 (3.8%) | – | |
History of TUR | |||
Primary | 20 (38.4%) | 50 (83.3%) | < 0,001 |
Secondary (2 or more) | 32 (61.5%) | 10 (16.6%) | |
NLR | 3.37 ± 1.87 | 2.225 ± 0.95 | 0.01 |
PLR | 116.8 ± 60.7 | 113.8 ± 51.6 | 0.8 |
General condition | < 0.001 | ||
Deceased | 32 (61.5%) | 2 (3.3%) | |